What is the best treatment for Enterococcus faecalis (E. faecalis) urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Treatment for Enterococcus faecalis Urinary Tract Infection

Amoxicillin 500 mg orally three times daily for 5-7 days is the recommended first-line treatment for Enterococcus faecalis urinary tract infections. 1

First-line Treatment Options

  • Amoxicillin: 500 mg orally every 8 hours (three times daily) for 5-7 days
    • This is the preferred treatment for enterococcal UTIs based on clinical guidelines
    • Generally effective against most E. faecalis strains
    • Safe to use during pregnancy if needed

Alternative Treatment Options (for penicillin-allergic patients or resistant strains)

  1. Nitrofurantoin: 100 mg orally twice daily for 5 days

    • High-quality evidence supports its use for uncomplicated lower UTIs
    • Contraindicated in patients with CrCl <30 mL/min or symptoms of pyelonephritis
    • Should not be used in pregnant patients near term
  2. Fosfomycin: 3 g orally as a single dose

    • Convenient single-dose regimen
    • Moderate-quality evidence supports its efficacy for lower UTIs
    • Good option for uncomplicated cases
  3. Linezolid: 600 mg orally twice daily for 5-7 days

    • Reserved for resistant strains, including vancomycin-resistant enterococci (VRE)
    • More expensive than other options
    • Has potential for more significant side effects

Special Considerations

Risk Factors for E. faecalis UTI

  • Indwelling urinary catheters (OR 2.05; 95% CI 1.15-3.65) 2
  • Previous urinary instrumentation (OR 2.16; 95% CI 1.08-4.34) 2
  • Male sex 3
  • Obstructive uropathy 3
  • Nosocomial infection 3
  • Cancers of the urinary system 3
  • Previous antimicrobial treatment 3

Complicated UTIs

  • For complicated UTIs or pyelonephritis, extend treatment to 10-14 days 1
  • Consider parenteral therapy for severe infections:
    • Daptomycin has been shown to be active against E. faecalis in clinical infections 4
    • For multidrug-resistant strains, options include daptomycin, linezolid, or quinupristin-dalfopristin 5

Catheter Management

  • Remove or exchange indwelling catheters if possible 1
  • Catheter removal is crucial for successful treatment and prevention of recurrence

Treatment Monitoring and Follow-up

  • Clinical improvement should be expected within 48-72 hours of starting treatment 1

  • If symptoms persist after completing the full course:

    • Obtain cultures with susceptibility testing
    • Evaluate for resistant organisms
    • Consider structural abnormalities or other complications
  • Routine post-treatment cultures are not indicated if symptoms resolve 1

  • For persistent or recurrent symptoms within 2 weeks, urine culture and susceptibility testing are recommended 1

Common Pitfalls to Avoid

  1. Inadequate empirical therapy: E. faecalis UTIs are often treated inadequately with empirical therapy (66.6% vs 19% for gram-negative UTIs) 2. Consider E. faecalis coverage in patients with risk factors.

  2. Treating asymptomatic bacteriuria: Avoid treating asymptomatic bacteriuria except in specific circumstances such as pregnancy or before urologic procedures with expected mucosal bleeding 1.

  3. Overuse of fluoroquinolones: These should be avoided for uncomplicated UTIs due to an unfavorable risk-benefit ratio 1.

  4. Inappropriate use of carbapenems: Reserve these for severe infections or treatment failures due to antimicrobial stewardship concerns 1.

  5. Failure to adjust therapy based on susceptibility: Always review culture results and adjust therapy accordingly, especially for complicated or recurrent infections.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.